Balchem Corporation Completes Acquisition of Chemogas
May 28 2019 - 8:30AM
Balchem Corporation (NASDAQ: BCPC) today announced that it
completed its acquisition of Chemogas, NV, a privately held
specialty gases company, headquartered in Grimbergen, Belgium. The
signing of a definitive agreement to acquire Chemogas, NV was
previously announced on May 2, 2019.
With this acquisition, Balchem significantly
expands its geographic presence in the packaged ethylene oxide
market, enabling the company to offer worldwide service and support
to its medical device sterilization customers. The Chemogas sites
in Europe and Asia will form a global network of facilities when
combined with Balchem’s sites in the United States, making Balchem
the clear global leader in the critical supply of ethylene oxide to
the medical device sterilization industry.
About Balchem Corporation
Balchem Corporation develops, manufactures and
markets specialty ingredients that improve and enhance the health
and well-being of life on the planet, providing state-of-the-art
solutions and the finest quality products for a range of industries
worldwide. The company reports four business segments: Human
Nutrition & Health; Animal Nutrition & Health; Specialty
Products; and Industrial Products. The Human Nutrition & Health
segment delivers customized food and beverage ingredient systems,
as well as key nutrients into a variety of applications across the
food, supplement and pharmaceutical industries. The Animal
Nutrition & Health segment manufactures and supplies products
to numerous animal health markets. Through Specialty Products,
Balchem provides specialty-packaged chemicals for use in healthcare
and other industries, and also provides chelated minerals to the
micronutrient agricultural market. The Industrial Products segment
manufactures and supplies certain derivative products into
industrial applications. For more information please
visit www.balchem.com.
Forward-Looking Statement
This release contains forward-looking
statements, which reflect Balchem’s expectation or belief
concerning future events that involve risks and uncertainties.
Balchem can give no assurance that the expectations reflected in
forward-looking statements will prove correct and various factors
could cause results to differ materially from Balchem’s
expectations, including risks and factors identified in Balchem’s
annual report on Form 10-K for the year ended December 31, 2018.
Forward-looking statements are qualified in their entirety by the
above cautionary statement. Balchem assumes no duty to update its
outlook or other forward-looking statements as of any future
date.
Contact: |
Mary Ann
Brush, Executive Assistant to CEO |
|
Telephone: 845-326-5600 |
|
E-mail: mabrush@balchem.com |
Balchem (NASDAQ:BCPC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Balchem (NASDAQ:BCPC)
Historical Stock Chart
From Sep 2023 to Sep 2024